Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mike Maloney: Gold & Silver Will Outperform Everything Else
$PVSP big revs for the company: Pervasip Announces $1.6 Million in August Revenues and 3rd Quarter Guidance https://finance.yahoo.com/news/pervasip-announces-1-6-million-131500755.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$PVSP 24 MONTH ROADMAP TO $50 MILLION IN SALES https://finance.yahoo.com/news/24-month-roadmap-50-million-131500092.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
You all should look at $LUDG today! The float is so small that even a couple of small buys and everybody goes up 50% or better on their money. Ludwig Inc also released a significant update on the deal with a big corporation and has filed a patent on proprietary technology, the "Ludwig mRNA Inflammatory Index™." which may further hit the PPS.
https://finance.yahoo.com/finance/news/ludwig-files-patent-could-major-113000503.html
$PVSP will continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines.
$HWAL..Price spike coming? Could be!>>>
$PVSP Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced its 2-year strategic roadmap.
“On the heels of Artizen Corporation’s reverse merger to acquire Pervasip Corp, the cannabis industry experienced a dramatic post pandemic contraction. Planned restructuring efforts had already launched in late 2021 and we took even more aggressive steps to further rationalize our business, dispose of undervalued assets, re-focus on higher margin products and allowed our leading brands to take a more aggressive posture to increase market share. Healthy inventory amounts provided for extraordinary financing via cashflow, albeit at extremely low margins, a carefully considered short term decision which has now come to an end as we have achieved our goals. All these efforts position us nicely for healthy financial growth in 2023. As promised, we have also finalized a 24-month roadmap and are in a position to provide carefully considered guidance in a market that is still extremely unpredictable,” said German Burtscher, Pervasip CEO. “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
Market Overview – Washington
The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.
$100M In Monthly Sales By Category
After several years of recreational sales, the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP SEATTLE, WASHINGTON, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management, today announced that Artizen reached sales of $1.6 million in August.
“Marking the best sales month ever is a testament to the hard work of the team and quality of Artizen branded products in these difficult market conditions,” says German Burtscher, Pervasip’s CEO. “August also marks the close of the 3rd quarter and the restructuring efforts of the last several months are starting to show improvement across many key financial performance indicators, including cashflow for Q3. As we further rationalize our business, including shedding of underperforming assets, we will continue to prioritize margins over revenue to build lasting financial health and strengthening fundamentals important to support our growth. We are achieving a more balanced ratio of revenues across all product categories which will serve the Company well as it goes into Q4.”
The Company also reports that various new product lines and planned near-term acquisitions will add revenue, new growth opportunities, and be a springboard for expansion into other recreational cannabis markets in the US.
$PVSP 24 MONTH ROADMAP TO $50 MILLION IN SALES https://finance.yahoo.com/news/24-month-roadmap-50-million-131500092.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$BLFR BlueFire Equipment, Corp. (BLFR), Acquires Miracle Life Farm, LLC., a 6 Year Family Owned Farm in Homestead FL with Approximately $3,400,000 in Assets and Revenue as of June 30, 2022 https://finance.yahoo.com/news/bluefire-equipment-corp-blfr-acquires-122500404.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$CLIS - ClickStream Corp.'s subsidiary Rebel Blockchain, Inc., aka Nifter™, is pioneering several firsts in the NFT sector. Nifter™ will be launching an artist advisory board to ensure the company takes the interests of artists at the highest decision-making level in the company.
Nifter™ is a strong advocate for the protection of artists' copyrights, monetization of art, and fair treatment. The advisory board will compromise some of the art, music, and entertainment industry's biggest names and advocates to bring depth and knowledge as Nifter™ grows. The global expansion also includes assigning dedicated talent agents in Asia and Africa.
https://finance.yahoo.com/news/nifter-tm-launches-talent-advisory-132000833.html
$IVDN: Patented House Wrap Insulation with Thermal Energy Saving Far Beyond Competition Gaining Recognition as Company Wins Court Case & 260K Cash Settlement: Innovative Designs, Inc.
Click here:
https://www.digitaljournal.com/pr/patented-house-wrap-insulation-with-thermal-energy-saving-far-beyond-competition-gaining-recognition-as-company-wins-court-case-260k-cash-settlement-innovative-designs-inc-otcqb-ivdn#ixzz7eEHyv3uY
Innovative Designs Inc. manufactures the Insultex(R) House Wrap, Arctic Armor(R) Line, under the "i.d.i.gear" label featuring INSULTEX(R). INSULTEX(R) is the thinnest, lightest, and warmest insulator in the market today. For more information, please visit http://www.idigear.com or http://www.insultexhousewrap.com.
$PVSP News: SEATTLE, WASHINGTON, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced its 2-year strategic roadmap.
“On the heels of Artizen Corporation’s reverse merger to acquire Pervasip Corp, the cannabis industry experienced a dramatic post pandemic contraction. Planned restructuring efforts had already launched in late 2021 and we took even more aggressive steps to further rationalize our business, dispose of undervalued assets, re-focus on higher margin products and allowed our leading brands to take a more aggressive posture to increase market share. Healthy inventory amounts provided for extraordinary financing via cashflow, albeit at extremely low margins, a carefully considered short term decision which has now come to an end as we have achieved our goals. All these efforts position us nicely for healthy financial growth in 2023. As promised, we have also finalized a 24-month roadmap and are in a position to provide carefully considered guidance in a market that is still extremely unpredictable,” said German Burtscher, Pervasip CEO. “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
Market Overview – Washington
The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.
$100M In Monthly Sales By Category
After several years of recreational sales, the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP 24 MONTH ROADMAP TO $50 MILLION IN SALES https://finance.yahoo.com/news/24-month-roadmap-50-million-131500092.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$PVSP With over 200,000 square feet of grow facility space under management, supporting a 30-person distribution center, and licensing the Artizen™ brand to cultivators in Washington State, ZAM is poised to expand its reach across the West coast and into Arizona and other recreational states.
Major waste management companies like Waste Management (NYSE: WM), Clean Harbor (NYSE: CLH), and Veolia Environnement (OTC: VEOEY) are implementing plastic waste and recycling programs in their jurisdictions. Other companies like Clean Vision Corp (OTC: CLNV) are helping to establish PCNs or plastic conversion networks that use pyrolysis to convert collected plastic waste into hydrogen-based fuel sources. Through its subsidiary CleanSeas, Clean Vision Corp. has already entered agreements with India, Sri Lanka, Morocco, and Turkey to install these PCNs. The clean Tech industry is a huge emerging sector and those who get in early will be benefitted the most. Add $CLNV to your watchlist as this company gets momentum.
https://pubcoinsight.com/clean-energy-stocks-29/
$PVSP Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$MYNZ Throughout the first half of 2022, Mainz executed its differentiated commercial plan of partnering with third-party laboratories for test kit processing versus the traditional methodology of operating a single facility. Under the standard terms of all partnerships, Mainz is providing ColoAlert to the respective labs, including co-branding with key accounts, whereby each facility purchases Mainz’s customized polymerase chain reaction (PCR) assay kits on an on-demand basis and provides their respective network of physicians and patients with a comprehensive solution for advanced CRC detection.
$PVSP we are Artizen cannabis and we are expanding rapidly nationwide and international markets too!
$PVSP 24 MONTH ROADMAP TO $50 MILLION IN SALES https://finance.yahoo.com/news/24-month-roadmap-50-million-131500092.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$TORVF~~The Race For Lithium Batteries..Volt Carbon Technologies
Kootenay Silver Drills 5,840 gpt Silver over 2.45 meters within 34.45 meters of 540 gpt Silver Columba High-Grade Silver Project, Mexico
Kootenay Silver Inc. (TSXV: KTN) (the "Company" or "Kootenay" is pleased to announce the final batch of results from its Phase 4 drilling program at Columba High-Grade Silver Project in Chihuahua State, Mexico. Results from eleven drill holes are reported here including seven from D Vein and four holes testing B Vein.
The current diamond drill exploration program was designed to step out on mineralized veins along strike and to depth within the target-rich Columba Silver Project, the program was paused due to slow turnaround of assays. Results herein represent the balance of assays awaited. Based upon the reported Phase 4 results, Kootenay has initiated design of an expanded drill program to target high priority veins to assess the large magnitude of the mineralized system at Columba. The F, D and B Veins will be targeted with step out along strike and to depth and numerous untested high-priority areas at Columba. Nearly all drill results across the project remain open to expansion.
The results below successfully extend known mineralization along strike and beneath existing drilling at both the D Vein and B Vein targets. The new results from Columba continue to demonstrate wide intervals of significant silver mineralization in wallrock zones adjacent the target veins, a feature often seen in mineralized drill intercepts across the project.
Drill Highlights:
D Vein
CDH-22-125
34.45 meters of 540 gpt silver with 0.26 gpt gold, 0.37% lead and 1.56% zinc in a wide stockwork zone includes:
9.7 meters of 1,746 gpt silver, 0.88 gpt gold, 1.11 % lead and 5.2% zinc in D Vein with;
2.45 meters of 5,840 gpt silver, 3.0 gpt gold, 3.08% lead and 17.25% zinc, a project best intercept to date.
Extends wide high grade 90 meters directly beneath previously announced high grade intercept (CDH-21-110) with 17.8 meters of 650 gpt silver, 0.98% lead and 2.2% zinc within 29 meters of 453 gpt silver, 0.6% lead and 1.43% zinc.
Total vertical extent of D Vein mineralization now 300 meters.
CDH-22-127
0.98 meters of 788 gpt silver, 0.64% lead and 1.33% zinc.
CDH-22-128
2.0. meters of 520 gpt silver within 20 meters of 136 gpt silver.
CDH-22-131
4.86 meters of 311 gpt Silver within 150 gpt silver over 16 meters.
Extends D Vein 100 meters along strike to the southeast from previous drilling.
Marks high-level expression of mineralized system at D Vein, an interpreted high-grade horizon preserved at depth.
B Vein
CDH-22-134
Intersected broad zone of mineralization though the B Vein corridor including 1.5 meters of 251 gpt silver, 0.1% lead and 0.15% zinc
Extends B Vein to the southeast, provides a test of the upper levels of the interpreted epithermal system.
Lower grade expected as hole was drilled to confirm dips with a shallow test above expected high grade zone.
Link to D Vein (long section, drill plan) and B Vein (long section, drill plan)
Kootenay Silver’s President and CEO Mr. James McDonald stated “The intersection in hole 125 confirms D Vein as a significant structure at Columba. Drilling since 2019 has returned high grade silver hits over excellent widths from veins across the property and we are eager to further advance the project with an aggressively expanded drilling program in the near future. Having traced the vein system over an area of three-by-four kilometers and seeing continuity of high grades and widths in areas like the D Vein underscore for us the potential for 100 plus million ounces of silver”
D Vein is a northwest striking, silver-bearing epithermal style vein with associated mineralized quartz stockwork and hydrothermal breccia. The vein has been drilled over a strike length of 425 meters to a depth of roughly 340 meters, the mapped extent is around 1,300 meters. Numerous mineralized structures are noted across the property, and all remain open for extension. Kootenay is developing an expanded drilling program to prioritize and continue to expand the mineralized footprint at Columba.
Holes from D Vein reported below (CDH-22-125 to CDH-22-129, CDH-22-131 and CDH-22-135) are part of a systematic exploration program designed to test high priority veins at Columba. The high-grade intercept in CDH-22-125 is located 50 meters below the nearest drill intercept to date. The intercept in CDH-22-135, the furthest drilling to the southeast, encountered the target at a high level in the system and as such was expected to be above the high-grade zone, indicating additional high-priority targets at depth.
B Vein is a southeast striking quartz vein in the southeastern quadrant of the main Columba drilling area. Surface work has identified the B Vein structure for up to 1,700 meters and to date B Vein has been drilled over a lateral distance of 270 meters. The best intercept at B Vein to date is of 4.6 meters averaging 1,186 gpt silver from drill hole CDH-20-082.
Website ; https://kootenaysilver.com/
D VEIN RESULTS
Hole ID
From (meters)
To
(meters)
Interval (meters)1
Silver (gpt)
Gold (gpt)
Pb (%)
Zn (%)
Geologic Description
CDH-22-125
183.0
184.83
1.83
158
0.06
0.20
Hydrothermal breccia
AND
269.6
304.0
34.45
540
0.26
0.37
1.56
Hydrothermal breccia, D vein and quartz stockwork
Including
283.1
292.8
9.70
1746
0.88
1.11
5.20
D Vein System
(sub interval)
283.1
289.7
6.60
2498
1.28
1.59
7.47
D Vein System
(sub interval)
286.0
288.5
2.45
5840
3.00
3.08
17.25
D Vein
CDH-22-126
230.0
244.63
14.63
135
0.08
0.18
Quartz Stockwork in rhyolite, D vein
Including
238.0
244.0
6.03
234
0.15
0.31
D Vein
(sub interval)
243.6
244.0
0.43
915
0.35
0.54
D Vein
AND
247.4
248.3
0.84
137
0.18
0.32
Quartz Stockwork in rhyolite, D vein
CDH-22-127
254.72
255.7
0.98
788
0.64
1.33
D Vein
AND
262.0
263.0
1.0
103
0.04
0.13
Quartz Stockwork in rhyolite, D vein
AND
275.0
276.0
1.0
136
0.01
0.11
Quartz Stockwork in rhyolite, D vein
CDH-22-128
245.0
265.0
20.0
136
0.09
0.22
D Vein System
Including
249.0
251.0
2.0
520
0.33
0.03
0.07
D Vein
AND
276.0
277.0
1.0
277
0.34
1.24
Quartz Stockwork in rhyolite
AND
282.0
284.0
2.0
136
0.58
1.29
Footwall vein
CDH-22-129
No
Significant
Results
D Vein
CDH-22-131
107.0
123.0
16.00
150
0.07
0.2
D Vein System
Including
116.0
120.9
4.86
311
0.17
0.38
D Vein
(sub interval)
118.0
118.6
0.59
603
0.02
0.13
D vein
CDH-22-135
104.89
108
3.11
100
156
285
D Vein
Including
106.05
106.92
0.87
234
210
180
D Vein
B VEIN RESULTS
CDH-22-130
No
Significant
Results
B Vein
CDH-22-132
No
Significant
Results
B Vein
CDH-22-133
No
Significant
Results
B Vein
CDH-22-134
233.4
240
6.6
109
349
1216
B Vein System
Including
235.5
237
1.5
251
1030
1510
B Vein System
AND
253.5
254
0.5
279
1330
2060
B Vein System
1True widths are estimated at between 65% an 85% of the downhole lengths.
A comprehensive list of drill results completed on the Columba Property since 2019 may be viewed here: Columba Drill Results.
Sampling and QA/QC at Columba
All technical information for the Columba exploration program is obtained and reported under a formal quality assurance and quality control ("QA/QC" program. Samples are taken from core cut in half with a diamond saw under the direction of qualified geologists and engineers. Samples are then labeled, placed in plastic bags, sealed and with interval and sample numbers recorded. Samples are delivered by the Company to ALS Minerals ("ALS" in Chihuahua. The Company inserts blanks, standards and duplicates at regular intervals as follows. On average a blank is inserted every 100 samples beginning at the start of sampling and again when leaving the mineral zone. Standards are inserted when entering the potential mineralized zone and in the middle of them, on average one in every 25 samples is a standard. Duplicates are taken in the mineralized zone, on average 1 to 2 duplicates for each hole.
The samples are dried, crushed and pulverized with the pulps being sent airfreight for analysis by ALS in Vancouver, B.C. Systematic assaying of standards, blanks and duplicates is performed for precision and accuracy. Analysis for silver, zinc, lead and copper and related trace elements was done by ICP four acid digestion, with gold analysis by 30-gram fire assay with an AA finish. All drilling reported is HQ core and has been contracted to Globexplore Drilling from Hermosillo, Sonora, Mexico.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Qualified Persons
The Kootenay technical information in this news release has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43-101 (Standards of Disclosure for Mineral Projects) and reviewed and approved on behalf of Kootenay by James McDonald, P.Geo, President, CEO & Director for Kootenay, a Qualified Person.
About Kootenay Silver Inc.
Kootenay Silver Inc. is an exploration company actively engaged in the discovery and development of mineral projects in the Sierra Madre Region of Mexico. Supported by one of the largest junior portfolios of silver assets in Mexico, Kootenay continues to provide its shareholders with significant leverage to silver prices. The Company remains focused on the expansion of its current silver resources, new discoveries and the near-term economic development of its priority silver projects located in prolific mining districts in Sonora, State and Chihuahua, State, Mexico, respectively.
For additional information, please contact:
James McDonald, CEO and President at 403-880-6016
Ken Berry, Chairman at 604-601-5652; 1-888-601-5650
Thanks Gollum $AMC $APE
$PVSP For all cannabis connoisseurs all that needs to be said about that brand is “IYKYK” (bestselling small batch top shelf brand). Several similar arrangements will be announced soon, following through on one of the other major initiatives outlined in the January 2022 Shareholder letter.
While the cannabis market on the west coast is still challenged by its post Covid dip, massive oversupply, and egregious tax and state by state rules, brands like ArtizenTM, well-oiled distribution, top notch management teams and healthy, transparent financial structures, will be the ultimate winners in this space.
$EDXC - ENDEXX Corp's Hyla acquisition will add new countries to its distribution network, and boost revenue..
$PVSP The Company's Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
$PVSP SEATTLE, WASHINGTON, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced its 2-year strategic roadmap.
“On the heels of Artizen Corporation’s reverse merger to acquire Pervasip Corp, the cannabis industry experienced a dramatic post pandemic contraction. Planned restructuring efforts had already launched in late 2021 and we took even more aggressive steps to further rationalize our business, dispose of undervalued assets, re-focus on higher margin products and allowed our leading brands to take a more aggressive posture to increase market share. Healthy inventory amounts provided for extraordinary financing via cashflow, albeit at extremely low margins, a carefully considered short term decision which has now come to an end as we have achieved our goals. All these efforts position us nicely for healthy financial growth in 2023. As promised, we have also finalized a 24-month roadmap and are in a position to provide carefully considered guidance in a market that is still extremely unpredictable,” said German Burtscher, Pervasip CEO. “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
Market Overview – Washington
The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.
$100M In Monthly Sales By Category
After several years of recreational sales, the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP in beautiful Port Townsend, on the northern end of the Olympic Peninsula, this gorgeous light deprivation greenhouse garden is producing beautiful flower and is home to some of the more exotic genetics in the Artizen brand. At 39,000 square feet it is the second largest of all of the gardens growing Artizen branded flower.
$PVSP 24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP German Burtscher, Pervasip CEO: “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
$HWAL..Just confirmed from reliable source HUGE PR coming!
$PVSP's Financial Outlook Q3 2022 through Q4 2023:
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP News: SEATTLE, WASHINGTON, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced its 2-year strategic roadmap.
“On the heels of Artizen Corporation’s reverse merger to acquire Pervasip Corp, the cannabis industry experienced a dramatic post pandemic contraction. Planned restructuring efforts had already launched in late 2021 and we took even more aggressive steps to further rationalize our business, dispose of undervalued assets, re-focus on higher margin products and allowed our leading brands to take a more aggressive posture to increase market share. Healthy inventory amounts provided for extraordinary financing via cashflow, albeit at extremely low margins, a carefully considered short term decision which has now come to an end as we have achieved our goals. All these efforts position us nicely for healthy financial growth in 2023. As promised, we have also finalized a 24-month roadmap and are in a position to provide carefully considered guidance in a market that is still extremely unpredictable,” said German Burtscher, Pervasip CEO. “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
Market Overview – Washington
The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.
$100M In Monthly Sales By Category
After several years of recreational sales, the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP 24 MONTH ROADMAP TO $50 MILLION IN SALES https://finance.yahoo.com/news/24-month-roadmap-50-million-131500092.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$PVSP developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced its 2-year strategic roadmap.
“On the heels of Artizen Corporation’s reverse merger to acquire Pervasip Corp, the cannabis industry experienced a dramatic post pandemic contraction. Planned restructuring efforts had already launched in late 2021 and we took even more aggressive steps to further rationalize our business, dispose of undervalued assets, re-focus on higher margin products and allowed our leading brands to take a more aggressive posture to increase market share. Healthy inventory amounts provided for extraordinary financing via cashflow, albeit at extremely low margins, a carefully considered short term decision which has now come to an end as we have achieved our goals. All these efforts position us nicely for healthy financial growth in 2023. As promised, we have also finalized a 24-month roadmap and are in a position to provide carefully considered guidance in a market that is still extremely unpredictable,” said German Burtscher, Pervasip CEO. “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
Market Overview – Washington
The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.
$100M In Monthly Sales By Category
After several years of recreational sales, the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP a developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced its 2-year strategic roadmap.
“On the heels of Artizen Corporation’s reverse merger to acquire Pervasip Corp, the cannabis industry experienced a dramatic post pandemic contraction. Planned restructuring efforts had already launched in late 2021 and we took even more aggressive steps to further rationalize our business, dispose of undervalued assets, re-focus on higher margin products and allowed our leading brands to take a more aggressive posture to increase market share. Healthy inventory amounts provided for extraordinary financing via cashflow, albeit at extremely low margins, a carefully considered short term decision which has now come to an end as we have achieved our goals. All these efforts position us nicely for healthy financial growth in 2023. As promised, we have also finalized a 24-month roadmap and are in a position to provide carefully considered guidance in a market that is still extremely unpredictable,” said German Burtscher, Pervasip CEO. “It is also important to note that all the Artizen brands’ revenue is wholesale, revenue derived from sales to retailers. The vast majority of MSOs report revenues and resulting financials that include retail sales from stores they own in addition to usually rather small wholesale revenue, all mostly generated in protected markets. Washington State (WA) cannabis sales are taxed at 47% (!) and each dollar sold by a producer/processor is marked up 3 – 3.5 times by the retailers they sell to. Generating profitable revenue in WA will translate extremely well once our brands and operating expertise is applied in other recreational markets.”
Market Overview – Washington
The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.
$100M In Monthly Sales By Category
After several years of recreational sales, the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.
Strategic Outlook Summary through Q4 2024
Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup
We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%
Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses
95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products
Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.
24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP will complete the audit and begin the OTC QB application process during Q2 2023.
Followers
|
287
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
54870
|
Created
|
02/20/15
|
Type
|
Free
|
Moderator mick | |||
Assistants Nilbud ospreyeye jedijazz imgoingfishing1 PhotoChick $Pistol Pete$ |
WELCOME FRIENDS TO "MICK AND FRIENDS STOCK PICKS" BOARD !!!
PLEASE POST :
1. YOUR STOCK PICK
2. WHY YOU ARE RECOMMENDING THE STOCK
3. A BIT OF INFO ON STOCK WOULD BE HELPFUL
FORUM FOR ALL STOCKS:
- NYSE
- NASDAQ
- AMEX
- OTCBB
- PINK SHEETS
- GRAY SHEETS
- FOREIGN EXCHANGES
FORUM NOT FOR ANY SPECIFIC STOCK
PLEASE, YOUR POST MUST NOT CONTAIN ANYTHING ABOUT "BASHING" ON ANY I-HUB STOCK BOARD.
THANK YOU AND ENJOY "MICK AND FRIENDS STOCK PICKS" BOARD.
Mick
PhotoChick
http://investorshub.advfn.com/STOCKGOODIES-PLAYS-OF-THE-WEEK-18582/
Photo Chick
Ospreyeye
Pistol Pete
Nilbud
imgoingfishing1
RECOMMENDED LINKS:
- FEATURE HISTORIANS CREATURES HIGHLIGHTS: http://investorshub.advfn.com/Weekend-Warrior$-27071/
- BUD-X-EXCHANGE HUGE MARIJUANA CANNABIS HEMP FINDS
- STOCKGOODIES PLAYS OF THE WEEK
- http://Pennystocksinsiders.com
- Billionaire Boys Club Member Forum (BBCMF
- INTELLECTUAL STOCK INVESTOR { I S I
- $$$Ospreyeye: Charts, Technical Analysis & Japanese
-Best of iHub
Moderator: JAYLIN Assistants: OTCRIDDLER, OTC_Skywalker, Sonic Boom, norcalpsl, Penny Soldier
LINKS
http://www.thehotpennystocks.com/Stock-Quotes/?stock=VTPI
http://www.quotemedia.com/
http://www.quotemedia.com/finance/quote/?qm_page=73166&qm_symbol=EFFI
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Posts Today
|
0
|
Posts (Total)
|
54870
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |